Latest Breaking News On - Affamed therapeutics - Page 7 : comparemela.com

AffaMed Therapeutics Announces IND Clearance by US FDA for AM712 - a Novel Bispecific Biologic for the Treatment of Retinal Vascular Diseases

/PRNewswire/ AffaMed Therapeutics ("AffaMed"), a global clinical stage biotechnology company dedicated to developing and commercializing transformative.

Successful Completion of First Patient Implantation of MINI WELL® and MINI WELL TORIC® Extended Depth-of-Focus IOLs in China Announced by Affamed Technologies, Joint Venture between AffaMed Therapeutics and SIFI

Read more about Successful Completion of First Patient Implantation of MINI WELL® and MINI WELL TORIC® Extended Depth-of-Focus IOLs in China Announced by Affamed Technologies, Joint Venture between AffaMed Therapeutics and SIFI on Devdiscourse

AffaMed Therapeutics Enters into Strategic Partnership Agreement with Beijing Tiantan Hospital and Infinite Brain Technologies to Promote Digital Therapy in Neurological Diseases

/PRNewswire/ AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to addressing critical unmet medical needs in.

AffaMed Therapeutics宣布与北京天坛医院及北京无疆科技签订战略合作协议-美通社PR-Newswire

北京2021年9月6日 /美通社/  致力于满足全球眼科、神经和精神系统疾病治疗需求的临床阶段创新生物医药公司 AffaMed Therapeutics（以下简称

Future Market Insights' 250 Pages Ocular Drug Delivery System Market Study Identifies Demand for Targeted Techniques for Ophthalmic Disease Treatment, a Chief Growth Driver